期刊文献+

左炔诺孕酮纳米粒缓释给药系统的研究 被引量:5

Study on sustained release drug delivery systems of levonorgestrol nanoparticles
下载PDF
导出
摘要 目的运用优化制备工艺,用可生物降解的材料制备性质稳定,缓释的左炔诺孕酮纳米粒(LNG-PBCA-NP).方法运用正交试验设计方法设计实验选出最优化实验条件,应用乳化聚合法制备LNG-PBCA-NP,观测粒径大小及分布,测量纳米药物的包封率和含药量,并测定体外释药速率.结果纳米粒粒径为72~170nm,分布均匀,包封率(87.6±0.47)%,控释时间延长.结论制备的LNG-PBCA-NP性质稳定,有明显的缓释性. Objective: To optimize the preparation with emulsification polymerizing method of Sustained Release Drug Delivery Systems of Levonorgestrol Nanoparticles with good anticonceptive effect using BCA as the biodegradable material. Methods: Use orthogonal design method to optimize the technology of preparation with good reproducibility, the appearance,particle size, drug content,drug release in vitro of the obtained microspheres were examined. Results: The particle size was 72~170 nm, which distributing uniformity.the precentage of drug content was (87.6±0.47)%. The time of drug release was prolonged. Conclusions: LNG -PBCA-NP character stability,the effect of sustained releasing drug was evident.
出处 《中国医学工程》 2004年第6期16-18,共3页 China Medical Engineering
关键词 纳米粒 左炔诺孕酮 给药系统 缓释性 NP 包封率 体外释药 延长 测定 粒径 levonorgestrol butyl cyanoacrylate nanoparticles sustained release drug delivery systems.
  • 相关文献

参考文献7

二级参考文献31

  • 1主皓,蒋雪涛,杨悦武,张万国.白蛋白微球中卡铂的络合分光光度测定方法的研究[J].药物分析杂志,1995,15(1):41-43. 被引量:21
  • 23,BP[S].1993.355
  • 3[1]Fox JL. Gene therapy safety issues come to fore[J]. Nat Biotechn ol, 1999, 17(12): 1153.
  • 4[2]Heng G, Yongjun L, Yuehong Z, et al. Nanoparticle as a new gene transferring vector in specific expression gene[J]. Chin Med Sci J, 2002, 17(4): 220 -224.
  • 5[3]Zobel HP, Kreuter J, Wemer D, et al. Cationic polyhexylcyanoacry late nanoparticles as carriers for antisense oligonucleotides. Anti sense Nucleic Acid Drug Dev, 1997, 7(5): 483 -493.
  • 6[4]Andreas Zimmer. Antisense oligonucleotide delivery with polyhexyl cyanoacrylate nanoparticles as carries[ J ]. METHODS: A compan ion to methods in enzymology, 1999, 18:286-295.
  • 7[5]Kneuer C, Sameti M, Bakowsky U, et al. A nonviral DNA delivery system based on surface modified silica - nanoparticles can efficiently transfect cells in vitro. Bioconjug Chem, 2000, 11 (6): 926 - 932.
  • 8[6]Vijayanathan V, Thomas T, Thomas TJ. DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Bliochemistry. 2002, 41 (48): 14085 - 14094.
  • 9[7]Zhu SG, Lu HB, Xiang JJ, et al. A new non -virus DNA delivery: poly - L - lysine - modified silica nanoparticles [ J ]. Chinese Sci ence Bulletin. 2002, 47 (3): 193 - 197.
  • 10Tiefenauer LX, Tschirky A, Kkne Get al. Invivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI.Magn Reson Imaging, 1996; 14(4) : 391 --394.

共引文献50

同被引文献44

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部